跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 161 条关于
“BSEP”
全部
161
临床试验
99
药物
46
机构
1
资讯
15
21天前
Rectify Pharmaceuticals Unveils RTY-406, an Oral Dual ABCB4/BSEP Modulator for Primary Sclerosing Cholangitis
3个月前
Rectify Pharmaceuticals Reports Promising Preclinical Data for RTY-406 in Primary Sclerosing Cholangitis at EASL 2026
2年前
Maralixibat Demonstrates Efficacy in Treating Pruritus and Reducing Bile Acids in PFIC Patients
去年
Rectify Pharma's Novel Dual-Targeted PFM Shows Promise for Hepatobiliary Diseases at EASL 2025
3天前
Japan Approves Buphenyl (Sodium Phenylbutyrate) for PFIC Types 1 and 2 After 20-Year Research Effort
2年前
FDA Expands Livmarli Approval for PFIC Patients Aged 12 Months and Older
去年
FDA Approves Tablet Formulation of LIVMARLI for Rare Pediatric Liver Diseases
2年前
FDA Approves Genentech's Ocrevus Zunovo as First Twice-Yearly Subcutaneous MS Treatment
去年
Genentech's Gazyva Shows Positive Phase III Results in Lupus Nephritis Treatment
去年
Optiscan doubles revenue, boosts profit for Sep qtr - Brisbane Times
第 1 页,共 2 页
上一页
下一页